PhD MRPharmS MPS(NZ) RegPharmNZ BPharm BA
Selected recent publications
- SHERIDAN, J.L., BUTLER, R., BRANDT, T, HARRISON, J., JENSEN, M., & SHAW, J.
Patients' and pharmacists' perceptions of a pilot Medicines Use Review service
in Auckland, New Zealand. Journal of Pharmaceutical Health Services Research,
10.1111/j.1759-8893.2011.00075.x, 2011
- SHERIDAN, J., BARNARD, M., WEBSTER, S. Influences on the provision of drug
services in England: the experiences and views of front line treatment workers
Health & Social Care in the Community. Volume 19, Issue 4, pages 403–411, 2011
- SHERIDAN, J., STEWART, J., SMART, R., MCCORMICK, R. Risky drinking among
community pharmacy customers in New Zealand and their attitudes towards
pharmacist screening and brief interventions. Drug Alcohol Rev. 2012 31(1):56-63
- DEERING, DEA., SHERIDAN, J., SELLMAN, JD., ADAMSON, SJ., POOLEY, S., ROBERTSON,
R., HENDERSON, C. Consumer and treatment provider perspectives on reducing
barriers to opioid substitution treatment and improving treatment
attractiveness. Addictive Behaviors 36(6):636-642 2011
- HARRISON, J., SCAHILL, S., SHERIDAN, J.L. New Zealand pharmacists’ alignment
with their professional body’s vision for the future. Research in Social and
Administrative. 2011 E-print
- HORSFIELD, E., SHERIDAN, J., KELLY, F., CLARK, T. Youth friendly pharmacies:
Exploring the role of community pharmacy in improving healthcare access for
young people in New Zealand. Youth Studies Australia, 29 (4): 38-45, 2010.
- SHERIDAN, J., KELLY, F., BASHEER, M., JAN, R., LEE, A. Can I help you? A
qualitative study of pharmacist and pharmacy assistant views on the role of
pharmacy assistants in New Zealand. International Journal of Pharmacy Practice,
online: DOI: 10.1111/j.2042-7174.2011.00096.x, 2011
- HORSFIELD, E., SHERIDAN, J., ANDERSON, C. What do community pharmacists think
about undertaking screening and brief interventions with problem drinkers?
Results of a qualitative study in New Zealand and England. International Journal
of Pharmacy Practice, 28 APR 2011I: 10.1111/j.2042-7174.2011.00112.x
- SHERIDAN, J.L., KELLY, F.S., OUGHTON, J.A., AL-JUBBAWEY, A., GREY, M., HUSSEIN,
S., JAYETILEKE, E., MEHTA, M., NAIR, S. Importation of Prescription Medicines
into New Zealand by the Public: a snapshot of six months of intercepted
products, Pharmacy World and Science, 33 (1), 80-87, 2011, DOI:
10.1007/s11096-010-9457-y
- ADAMSON, S., DEERING, D., SELLMAN, D., SHERIDAN, J.L., HENDERSON, C., ROBERTSON,
R.S., POOLEY, S.A., CAMPBELL, S., FRAMPTON, C. An estimation of the prevalence
of opioid dependence in New Zealand, International Journal of Drug Policy, 36,
636-642, 2011
- SHERIDAN, J., BUTLER, R. Prescription drug misuse in New Zealand: challenges for
primary healthcare professionals. Research in Social and Administrative
Pharmacy. 7(3):281-93 2011
- SMART, R., MCCORMICK, I.R.N., SHERIDAN, J.L. Estimating problem drinking amongst
community pharmacy customers: what did pharmacists think of the methodology?,
International Journal of Pharmacy Practice, 18: 290–296, 2010
- BUTLER, R.A., SHERIDAN, J.L., Innocent parties or devious drug users: the views
of primary healthcare practitioners with respect to those who misuse
prescription drugs, Harm Reduction Journal, 2010, 7:21
doi:10.1186/1477-7517-7-21
Read more
- JAN, R.K., LIN, J.C., LEE, H., SHERIDAN, J.L., KYDD, R.R., KIRK, I.J., RUSSELL,
B.R. Determining the subjective effects of TFMPP in human males,
Psychopharmacology, 211 (3), 347-353, 2010PULFORD, J., ADAMS, P.J., SHERIDAN,
J.L. Responding to treatment dropout: a review of controlled trials and
suggested future directions, Addiction Research and Theory, 18, (3), 298-315,
2010
- PULFORD, J., ADAMS, P., SHERIDAN, J. What do clients want from alcohol and other
drug treatment services? A mixed methods examination. Addiction Research &
Theory. 19( 3): 224-234 2011
- SCAHILL, S.L., HARRISON, J., SHERIDAN, J. Pharmacy under the spotlight: New
Zealand pharmacists’ perceptions of current and future roles and the need for
accreditation, International Journal of Pharmacy Practice, 18 (1), 59-62 2010
- WINSTOCK, A., LEA, T., SHERIDAN, J.L. Problems experienced by community
pharmacists delivering opioid substitution treatment in New South Wales and
Victoria, Australia, Addiction, 2010, 105(2):335-42
- SHERIDAN, J.L., BUTLER, R.A. "They're legal so they're safe, right?" What did
the legal status of BZP-party pills mean to young people in New Zealand?,
International Journal of Drug Policy, 21(1), 77-81, 2010
- MAYET, S., MANNING, V., SHERIDAN, J. BEST, D., STRANG, J. The virtual
disappearance of injectable opioids for heroin addiction under the ‘British
System’', Drugs: Education, Prevention, and Policy, 17(5): 496–506 2010
- PULFORD, J., BLACK, S. WHEELER, A., SHERIDAN, J. ADAMS, P. Providing post
treatment support in an out-patient alcohol, and other drug treatment context: a
qualitative study of staff opinion, International Journal of Mental Health and
Addiction, 8(3):493-502 2010
- SHERIDAN, J.L., BUTLER, R.A. "They're legal so they're safe, right?" What did
the legal status of BZP-party pills mean to young people in New Zealand?,
International Journal of Drug Policy21(1), 77-81, 2010
- SCAHILL, S.L., HARRISON, J., SHERIDAN, J. The ABC of New Zealand's 'Ten Year
Vision for Pharmacists': awareness, barriers and consultation. International
Journal of Pharmacy Practice, International Journal of Pharmacy Practice, 17(3),
135-142, 2009
- WINSTOCK, A., LEA, T., SHERIDAN, J.L. Problems experienced by community
pharmacists delivering opioid substitution treatment in New South Wales and
Victoria, Australia, Addiction 105(2):335-42 2010
- BUTLER, R.A., WHEELER, A.J., SHERIDAN, J.L. Physical and Psychological Harms and
Health Consequences of Methamphetamine Use Amongst a Group of New Zealand Users,
International Journal of Mental Health and Addictions, 8(3): 432-443 2009
- WINSTOCK, A., LEA, T., SHERIDAN, J.L. What is diversion of supervised
buprenorphine and how common is it?, Journal of Addictive Diseases, 28, (3),
p269-278, 2009
- PULFORD, J., ADAMS, P.J., SHERIDAN, J.L. Developing a clinical assessment model
suited to use in an agency providing short-term substance use treatment:
findings from a Delphi survey of expert opinion, Administration and Policy in
Mental Health and Mental Health Services Research, 36, (5), p322-330, 2009
- DUNBAR, L., MILES, W., WHEELER, A.J., SHERIDAN, J.L., PULFORD, J., BUTLER, R.A.
'The CYP450 metaboliser status of patients prescribed risperidone for the
treatment of psychosis', New Zealand Medical Journal, 122 (1296) 29-34, 2009
Read more
- WHEELER, A.J., HUMBERSTONE, V., ROBINSON, E.M., SHERIDAN, J.L. JOYCE,.P. Impact
and audit feedback on antipsychotic prescribing in schizophrenia, Journal of
Evaluation in Clinical Practice, 15, 3, 441-450, 2009
- SHERIDAN, J.L., BUTLER, R.A., WHEELER, A.J. Initiation into methamphetamine use:
qualitative findings from an exploration of first time use amongst a group of
New Zealand users, Journal of Psychoactive Drugs, 41, (1), p11-17, 2009
- PULFORD, J., ADAMS, P.J., SHERIDAN, J.L. 'Therapist attitudes and beliefs
relevant to client dropout revisited', Community Mental Health Journal, 44,
p181-186, 2008SHERIDAN, J.L., WHEELER, A.J., CHEN, L., HUANG, A. and 2 others
'Screening and brief interventions for alcohol: attitudes, knowledge and
experience of community pharmacists in Auckland, New Zealand', Drug and Alcohol
Review, 27, p380-387, 2008
- WINSTOCK, A., LEA, T., SHERIDAN, J.L. 'Patients' help-seeking behaviours for
health problems associated with methadone and buprenorphine treatment', Drug and
Alcohol Review, 27, p393-397, 2008
- SHERIDAN, J.L., MCMILLAN, K., WHEELER, A.J., LOVELL, C., LEE, A.W., AMERATUNGA,
S.N. Methamphetamine and injury - a survey of individuals attending a one-day
music festival in New Zealand: Piloting a new methodology, Journal of Substance
Use, 13, (1), p49-56, 2008
- SHERIDAN, J.L., GOODYEAR-SMITH, F.A., BUTLER, R.A., WHEELER, A.J., GOHNS, A.
Barriers to, and incentives for, the transfer of opioid-dependent people on
methadone maintenance treatment from secondary to primary health care, Drug and
Alcohol Review, 27, (3), p178-184, 2008
- WHEELER, A.J., SHERIDAN, J.L., ROBINSON, G., BRANFORD, D., HOLMES, N. Developing
clinical practice guidelines for the medication management of acute behavioural
disturbance in a New Zealand hospital, Journal of Pharmacy Practice and
Research, 37, p33-37, 2007
- SHERIDAN, J.L., KAIRUZ, T., BUTLER, R.A. Reporting Purchasers of Pseudoephedrine
Products to Police: New Zealand Community Pharmacists Experiences, Journal of
Pharmacy Practice and Research, 37, p19-21, 2007
- BUTLER, R.A., SHERIDAN, J.L., KAIRUZ, T. New Zealand community
pharmacists, experiences in collecting information from purchasers of
pseudoephedrine-containing products: findings from a qualitative study,
Pharmaceutical Journal, 278, p491-494, 2007
- SHERIDAN, J.L., MANNING, V., RIDGE, G., MAYET, S., STRANG, J. Community
pharmacies and the provision of opioid substitution services for drug misusers:
changes in activity and attitudes of community pharmacists across England
1995-2005, Addiction, 102, (11), p1824-1830, 2007
- BUTLER, R.A., SHERIDAN, J.L. Highs and lows: patterns of use, positive and
negative effects of benzylpiperazine-containing party pills (BZP-party pills)
amongst young people in New Zealand, Harm Reduction Journal, 4, (18), p1-10,
2007
Read more
- WHEELER, A.J., KAIRUZ, T., SHERIDAN, J.L., MCPHEE, E. Sedative-hypnotic
treatment in an acute psychiatric setting: comparison with best practice
guidance, Pharmacy World and Science, ifirst, p1-8, 2007
- CHRISTIE, G., MARSH, R., SHERIDAN, J.L., WHEELER, A.J., SUAALII-SAUNI, T.M.,
BLACK, S., BUTLER, R.A. The Substances and Choices Scale (SACS) - the
development and testing of a new alcohol and other drug screening and outcome
measurement instrument for young people, Addiction, 102, (9), p1390-1398, 2007
- KAIRUZ, T.E., SVIRSKIS, D., SHERIDAN, J.L. Children’s medicines - parents
perceptions on dosing intervals, dosing devices and prescription advice,
International Journal of Pharmacy Practice, 15, (1), p11-15, 2007
- WHEELER, A., KAIRUZ, T.E., MCPHEE, E., SHERIDAN, J.L. Sedative-hypnotic
treatment in an acute psychiatric setting, Pharmacy World and Science,
10.1007/s1, p1-8, 2007
- WHEELER, A., SHERIDAN, J.L., CHAN, G.C., CU, E.L., LEE, S.J., LO, R., WILLIAMS,
H.J., WONG, L. Audit of medication management of acute behavioural disturbance:
exploring the impact of a clinical practice, International Journal of Pharmacy
Practice, 15, (1), p75-78, 2007
- STRANG, J., MANNING, V., MAYET, S., RIDGE, G., BEST, D., SHERIDAN, J.L. Does
opiate prescribing for addiction change after national guidelines? Methadone and
buprenorphine prescribing to opiate addicts by general practitioners and
hospital doctors in England, 1995-2005, Addiction, 102, (5), p761-770, 2007
- SHERIDAN, J.L., BUTLER, R.A., WILKINS, C., RUSSELL, B.R. Legal
piperazine-containing party pills - a new trend in substance misuse, Drug and
Alcohol Review - Harm Reduction Digest, 26, (3), p335-343, 2007
|
